1. Home
  2. EDSA vs GIGM Comparison

EDSA vs GIGM Comparison

Compare EDSA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • GIGM
  • Stock Information
  • Founded
  • EDSA 2015
  • GIGM 1998
  • Country
  • EDSA Canada
  • GIGM Taiwan
  • Employees
  • EDSA N/A
  • GIGM N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • EDSA Health Care
  • GIGM Technology
  • Exchange
  • EDSA Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • EDSA 17.2M
  • GIGM 17.0M
  • IPO Year
  • EDSA N/A
  • GIGM 2000
  • Fundamental
  • Price
  • EDSA $2.39
  • GIGM $1.81
  • Analyst Decision
  • EDSA Strong Buy
  • GIGM
  • Analyst Count
  • EDSA 2
  • GIGM 0
  • Target Price
  • EDSA $13.00
  • GIGM N/A
  • AVG Volume (30 Days)
  • EDSA 11.7K
  • GIGM 22.4K
  • Earning Date
  • EDSA 08-08-2025
  • GIGM 10-29-2025
  • Dividend Yield
  • EDSA N/A
  • GIGM N/A
  • EPS Growth
  • EDSA N/A
  • GIGM N/A
  • EPS
  • EDSA N/A
  • GIGM N/A
  • Revenue
  • EDSA N/A
  • GIGM $3,250,000.00
  • Revenue This Year
  • EDSA N/A
  • GIGM N/A
  • Revenue Next Year
  • EDSA N/A
  • GIGM N/A
  • P/E Ratio
  • EDSA N/A
  • GIGM N/A
  • Revenue Growth
  • EDSA N/A
  • GIGM N/A
  • 52 Week Low
  • EDSA $1.55
  • GIGM $1.30
  • 52 Week High
  • EDSA $5.00
  • GIGM $1.89
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.55
  • GIGM 66.43
  • Support Level
  • EDSA $2.41
  • GIGM $1.61
  • Resistance Level
  • EDSA $2.47
  • GIGM $1.89
  • Average True Range (ATR)
  • EDSA 0.09
  • GIGM 0.09
  • MACD
  • EDSA -0.01
  • GIGM 0.02
  • Stochastic Oscillator
  • EDSA 48.15
  • GIGM 80.05

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: